Medical Care

Global CRISPR-Cas9 Nuclease Market Research Report 2025

The global market for CRISPR-Cas9 Nuclease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for CRISPR-Cas9 Nuclease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CRISPR-Cas9 Nuclease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CRISPR-Cas9 Nuclease in Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CRISPR-Cas9 Nuclease include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc, Sigma Aldrich, Genscript, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR-Cas9 Nuclease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR-Cas9 Nuclease.
The CRISPR-Cas9 Nuclease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR-Cas9 Nuclease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR-Cas9 Nuclease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
TriLink BioTechnologies
Qiagen
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Horizon Discovery Plc
Sigma Aldrich
Genscript
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Aldevron
Takara Bio
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR-Cas9 Nuclease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR-Cas9 Nuclease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR-Cas9 Nuclease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR-Cas9 Nuclease Market Perspective (2020-2031)
2.2 Global CRISPR-Cas9 Nuclease Growth Trends by Region
2.2.1 Global CRISPR-Cas9 Nuclease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRISPR-Cas9 Nuclease Historic Market Size by Region (2020-2025)
2.2.3 CRISPR-Cas9 Nuclease Forecasted Market Size by Region (2026-2031)
2.3 CRISPR-Cas9 Nuclease Market Dynamics
2.3.1 CRISPR-Cas9 Nuclease Industry Trends
2.3.2 CRISPR-Cas9 Nuclease Market Drivers
2.3.3 CRISPR-Cas9 Nuclease Market Challenges
2.3.4 CRISPR-Cas9 Nuclease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR-Cas9 Nuclease Players by Revenue
3.1.1 Global Top CRISPR-Cas9 Nuclease Players by Revenue (2020-2025)
3.1.2 Global CRISPR-Cas9 Nuclease Revenue Market Share by Players (2020-2025)
3.2 Global CRISPR-Cas9 Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRISPR-Cas9 Nuclease Revenue
3.4 Global CRISPR-Cas9 Nuclease Market Concentration Ratio
3.4.1 Global CRISPR-Cas9 Nuclease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Cas9 Nuclease Revenue in 2024
3.5 Global Key Players of CRISPR-Cas9 Nuclease Head office and Area Served
3.6 Global Key Players of CRISPR-Cas9 Nuclease, Product and Application
3.7 Global Key Players of CRISPR-Cas9 Nuclease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR-Cas9 Nuclease Breakdown Data by Type
4.1 Global CRISPR-Cas9 Nuclease Historic Market Size by Type (2020-2025)
4.2 Global CRISPR-Cas9 Nuclease Forecasted Market Size by Type (2026-2031)
5 CRISPR-Cas9 Nuclease Breakdown Data by Application
5.1 Global CRISPR-Cas9 Nuclease Historic Market Size by Application (2020-2025)
5.2 Global CRISPR-Cas9 Nuclease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRISPR-Cas9 Nuclease Market Size (2020-2031)
6.2 North America CRISPR-Cas9 Nuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRISPR-Cas9 Nuclease Market Size by Country (2020-2025)
6.4 North America CRISPR-Cas9 Nuclease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR-Cas9 Nuclease Market Size (2020-2031)
7.2 Europe CRISPR-Cas9 Nuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRISPR-Cas9 Nuclease Market Size by Country (2020-2025)
7.4 Europe CRISPR-Cas9 Nuclease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR-Cas9 Nuclease Market Size (2020-2031)
8.2 Asia-Pacific CRISPR-Cas9 Nuclease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRISPR-Cas9 Nuclease Market Size by Region (2020-2025)
8.4 Asia-Pacific CRISPR-Cas9 Nuclease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR-Cas9 Nuclease Market Size (2020-2031)
9.2 Latin America CRISPR-Cas9 Nuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRISPR-Cas9 Nuclease Market Size by Country (2020-2025)
9.4 Latin America CRISPR-Cas9 Nuclease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR-Cas9 Nuclease Market Size (2020-2031)
10.2 Middle East & Africa CRISPR-Cas9 Nuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRISPR-Cas9 Nuclease Market Size by Country (2020-2025)
10.4 Middle East & Africa CRISPR-Cas9 Nuclease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher CRISPR-Cas9 Nuclease Introduction
11.1.4 Thermo Fisher Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.1.5 Thermo Fisher Recent Development
11.2 TriLink BioTechnologies
11.2.1 TriLink BioTechnologies Company Details
11.2.2 TriLink BioTechnologies Business Overview
11.2.3 TriLink BioTechnologies CRISPR-Cas9 Nuclease Introduction
11.2.4 TriLink BioTechnologies Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.2.5 TriLink BioTechnologies Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen CRISPR-Cas9 Nuclease Introduction
11.3.4 Qiagen Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.3.5 Qiagen Recent Development
11.4 Editas Medicine
11.4.1 Editas Medicine Company Details
11.4.2 Editas Medicine Business Overview
11.4.3 Editas Medicine CRISPR-Cas9 Nuclease Introduction
11.4.4 Editas Medicine Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.4.5 Editas Medicine Recent Development
11.5 Caribou Biosciences
11.5.1 Caribou Biosciences Company Details
11.5.2 Caribou Biosciences Business Overview
11.5.3 Caribou Biosciences CRISPR-Cas9 Nuclease Introduction
11.5.4 Caribou Biosciences Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.5.5 Caribou Biosciences Recent Development
11.6 CRISPR therapeutics
11.6.1 CRISPR therapeutics Company Details
11.6.2 CRISPR therapeutics Business Overview
11.6.3 CRISPR therapeutics CRISPR-Cas9 Nuclease Introduction
11.6.4 CRISPR therapeutics Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.6.5 CRISPR therapeutics Recent Development
11.7 Intellia therapeutics, Inc.
11.7.1 Intellia therapeutics, Inc. Company Details
11.7.2 Intellia therapeutics, Inc. Business Overview
11.7.3 Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Introduction
11.7.4 Intellia therapeutics, Inc. Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.7.5 Intellia therapeutics, Inc. Recent Development
11.8 Horizon Discovery Plc
11.8.1 Horizon Discovery Plc Company Details
11.8.2 Horizon Discovery Plc Business Overview
11.8.3 Horizon Discovery Plc CRISPR-Cas9 Nuclease Introduction
11.8.4 Horizon Discovery Plc Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.8.5 Horizon Discovery Plc Recent Development
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich CRISPR-Cas9 Nuclease Introduction
11.9.4 Sigma Aldrich Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.9.5 Sigma Aldrich Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR-Cas9 Nuclease Introduction
11.10.4 Genscript Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.10.5 Genscript Recent Development
11.11 Integrated DNA Technologies
11.11.1 Integrated DNA Technologies Company Details
11.11.2 Integrated DNA Technologies Business Overview
11.11.3 Integrated DNA Technologies CRISPR-Cas9 Nuclease Introduction
11.11.4 Integrated DNA Technologies Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.11.5 Integrated DNA Technologies Recent Development
11.12 New England Biolabs
11.12.1 New England Biolabs Company Details
11.12.2 New England Biolabs Business Overview
11.12.3 New England Biolabs CRISPR-Cas9 Nuclease Introduction
11.12.4 New England Biolabs Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.12.5 New England Biolabs Recent Development
11.13 Origene Technologies
11.13.1 Origene Technologies Company Details
11.13.2 Origene Technologies Business Overview
11.13.3 Origene Technologies CRISPR-Cas9 Nuclease Introduction
11.13.4 Origene Technologies Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.13.5 Origene Technologies Recent Development
11.14 Aldevron
11.14.1 Aldevron Company Details
11.14.2 Aldevron Business Overview
11.14.3 Aldevron CRISPR-Cas9 Nuclease Introduction
11.14.4 Aldevron Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.14.5 Aldevron Recent Development
11.15 Takara Bio
11.15.1 Takara Bio Company Details
11.15.2 Takara Bio Business Overview
11.15.3 Takara Bio CRISPR-Cas9 Nuclease Introduction
11.15.4 Takara Bio Revenue in CRISPR-Cas9 Nuclease Business (2020-2025)
11.15.5 Takara Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CRISPR-Cas9 Nuclease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR-Cas9 Nuclease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global CRISPR-Cas9 Nuclease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global CRISPR-Cas9 Nuclease Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global CRISPR-Cas9 Nuclease Market Share by Region (2020-2025)
Table 13. Global CRISPR-Cas9 Nuclease Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global CRISPR-Cas9 Nuclease Market Share by Region (2026-2031)
Table 15. CRISPR-Cas9 Nuclease Market Trends
Table 16. CRISPR-Cas9 Nuclease Market Drivers
Table 17. CRISPR-Cas9 Nuclease Market Challenges
Table 18. CRISPR-Cas9 Nuclease Market Restraints
Table 19. Global CRISPR-Cas9 Nuclease Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global CRISPR-Cas9 Nuclease Market Share by Players (2020-2025)
Table 21. Global Top CRISPR-Cas9 Nuclease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Cas9 Nuclease as of 2024)
Table 22. Ranking of Global Top CRISPR-Cas9 Nuclease Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by CRISPR-Cas9 Nuclease Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of CRISPR-Cas9 Nuclease, Headquarters and Area Served
Table 25. Global Key Players of CRISPR-Cas9 Nuclease, Product and Application
Table 26. Global Key Players of CRISPR-Cas9 Nuclease, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR-Cas9 Nuclease Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global CRISPR-Cas9 Nuclease Revenue Market Share by Type (2020-2025)
Table 30. Global CRISPR-Cas9 Nuclease Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global CRISPR-Cas9 Nuclease Revenue Market Share by Type (2026-2031)
Table 32. Global CRISPR-Cas9 Nuclease Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global CRISPR-Cas9 Nuclease Revenue Market Share by Application (2020-2025)
Table 34. Global CRISPR-Cas9 Nuclease Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global CRISPR-Cas9 Nuclease Revenue Market Share by Application (2026-2031)
Table 36. North America CRISPR-Cas9 Nuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America CRISPR-Cas9 Nuclease Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America CRISPR-Cas9 Nuclease Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe CRISPR-Cas9 Nuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe CRISPR-Cas9 Nuclease Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe CRISPR-Cas9 Nuclease Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific CRISPR-Cas9 Nuclease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific CRISPR-Cas9 Nuclease Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific CRISPR-Cas9 Nuclease Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America CRISPR-Cas9 Nuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America CRISPR-Cas9 Nuclease Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America CRISPR-Cas9 Nuclease Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa CRISPR-Cas9 Nuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa CRISPR-Cas9 Nuclease Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa CRISPR-Cas9 Nuclease Market Size by Country (2026-2031) & (US$ Million)
Table 51. Thermo Fisher Company Details
Table 52. Thermo Fisher Business Overview
Table 53. Thermo Fisher CRISPR-Cas9 Nuclease Product
Table 54. Thermo Fisher Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Recent Development
Table 56. TriLink BioTechnologies Company Details
Table 57. TriLink BioTechnologies Business Overview
Table 58. TriLink BioTechnologies CRISPR-Cas9 Nuclease Product
Table 59. TriLink BioTechnologies Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 60. TriLink BioTechnologies Recent Development
Table 61. Qiagen Company Details
Table 62. Qiagen Business Overview
Table 63. Qiagen CRISPR-Cas9 Nuclease Product
Table 64. Qiagen Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 65. Qiagen Recent Development
Table 66. Editas Medicine Company Details
Table 67. Editas Medicine Business Overview
Table 68. Editas Medicine CRISPR-Cas9 Nuclease Product
Table 69. Editas Medicine Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 70. Editas Medicine Recent Development
Table 71. Caribou Biosciences Company Details
Table 72. Caribou Biosciences Business Overview
Table 73. Caribou Biosciences CRISPR-Cas9 Nuclease Product
Table 74. Caribou Biosciences Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 75. Caribou Biosciences Recent Development
Table 76. CRISPR therapeutics Company Details
Table 77. CRISPR therapeutics Business Overview
Table 78. CRISPR therapeutics CRISPR-Cas9 Nuclease Product
Table 79. CRISPR therapeutics Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 80. CRISPR therapeutics Recent Development
Table 81. Intellia therapeutics, Inc. Company Details
Table 82. Intellia therapeutics, Inc. Business Overview
Table 83. Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Product
Table 84. Intellia therapeutics, Inc. Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 85. Intellia therapeutics, Inc. Recent Development
Table 86. Horizon Discovery Plc Company Details
Table 87. Horizon Discovery Plc Business Overview
Table 88. Horizon Discovery Plc CRISPR-Cas9 Nuclease Product
Table 89. Horizon Discovery Plc Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 90. Horizon Discovery Plc Recent Development
Table 91. Sigma Aldrich Company Details
Table 92. Sigma Aldrich Business Overview
Table 93. Sigma Aldrich CRISPR-Cas9 Nuclease Product
Table 94. Sigma Aldrich Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 95. Sigma Aldrich Recent Development
Table 96. Genscript Company Details
Table 97. Genscript Business Overview
Table 98. Genscript CRISPR-Cas9 Nuclease Product
Table 99. Genscript Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 100. Genscript Recent Development
Table 101. Integrated DNA Technologies Company Details
Table 102. Integrated DNA Technologies Business Overview
Table 103. Integrated DNA Technologies CRISPR-Cas9 Nuclease Product
Table 104. Integrated DNA Technologies Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 105. Integrated DNA Technologies Recent Development
Table 106. New England Biolabs Company Details
Table 107. New England Biolabs Business Overview
Table 108. New England Biolabs CRISPR-Cas9 Nuclease Product
Table 109. New England Biolabs Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 110. New England Biolabs Recent Development
Table 111. Origene Technologies Company Details
Table 112. Origene Technologies Business Overview
Table 113. Origene Technologies CRISPR-Cas9 Nuclease Product
Table 114. Origene Technologies Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 115. Origene Technologies Recent Development
Table 116. Aldevron Company Details
Table 117. Aldevron Business Overview
Table 118. Aldevron CRISPR-Cas9 Nuclease Product
Table 119. Aldevron Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 120. Aldevron Recent Development
Table 121. Takara Bio Company Details
Table 122. Takara Bio Business Overview
Table 123. Takara Bio CRISPR-Cas9 Nuclease Product
Table 124. Takara Bio Revenue in CRISPR-Cas9 Nuclease Business (2020-2025) & (US$ Million)
Table 125. Takara Bio Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report


List of Figures
Figure 1. CRISPR-Cas9 Nuclease Picture
Figure 2. Global CRISPR-Cas9 Nuclease Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CRISPR-Cas9 Nuclease Market Share by Type: 2024 VS 2031
Figure 4. Genome Editing Features
Figure 5. Genetic Engineering Features
Figure 6. gRNA Database/Gene Librar Features
Figure 7. CRISPR Plasmid Features
Figure 8. Human Stem Cells Features
Figure 9. Genetically Modified Organisms/Crops Features
Figure 10. Cell Line Engineering Features
Figure 11. Global CRISPR-Cas9 Nuclease Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global CRISPR-Cas9 Nuclease Market Share by Application: 2024 VS 2031
Figure 13. Biotechnology Companies Case Studies
Figure 14. Pharmaceutical Companies Case Studies
Figure 15. Academic Institutes Case Studies
Figure 16. Research and Development Institutes Case Studies
Figure 17. CRISPR-Cas9 Nuclease Report Years Considered
Figure 18. Global CRISPR-Cas9 Nuclease Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global CRISPR-Cas9 Nuclease Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global CRISPR-Cas9 Nuclease Market Share by Region: 2024 VS 2031
Figure 21. Global CRISPR-Cas9 Nuclease Market Share by Players in 2024
Figure 22. Global Top CRISPR-Cas9 Nuclease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Cas9 Nuclease as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by CRISPR-Cas9 Nuclease Revenue in 2024
Figure 24. North America CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America CRISPR-Cas9 Nuclease Market Share by Country (2020-2031)
Figure 26. United States CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe CRISPR-Cas9 Nuclease Market Share by Country (2020-2031)
Figure 30. Germany CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific CRISPR-Cas9 Nuclease Market Share by Region (2020-2031)
Figure 38. China CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America CRISPR-Cas9 Nuclease Market Share by Country (2020-2031)
Figure 46. Mexico CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa CRISPR-Cas9 Nuclease Market Share by Country (2020-2031)
Figure 50. Turkey CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE CRISPR-Cas9 Nuclease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Thermo Fisher Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 54. TriLink BioTechnologies Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 55. Qiagen Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 56. Editas Medicine Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 57. Caribou Biosciences Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 58. CRISPR therapeutics Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 59. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 60. Horizon Discovery Plc Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 61. Sigma Aldrich Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 62. Genscript Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 63. Integrated DNA Technologies Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 64. New England Biolabs Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 65. Origene Technologies Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 66. Aldevron Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 67. Takara Bio Revenue Growth Rate in CRISPR-Cas9 Nuclease Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies